Literature DB >> 6934519

Priming and inhibitory activities of RNAs for the influenza viral transcriptase do not require base pairing with the virion template RNA.

R M Krug, B A Broni, A J LaFiandra, M A Morgan, A J Shatkin.   

Abstract

Capped ribopolymers lacking a sequence complementary to the common 3' end of the influenza virion RNA segments effectively stimulated transcription of these RNAs by the virion-associated transcriptase. Thus, stimulation of transcription results not from hydrogen bonding between the capped RNA and the 3' end of the virion RNA but presumably from a specific interaction of the capped RNA with protein(s) in the transcriptase complex. Although no specific nucleotide sequence was required for priming activity, capped mRNAs with diminished secondary structure were preferred as primers. Inosine-substituted or bisulfite-modified capped reovirus mRNAs were at least 3- to 5-fold more effective as primers than were the native capped mRNAs. On the other hand, inosine substitution or bisulfite treatment of the uncapped form of reovirus mRNAs converted them from essentially inactive species to potent inhibitors of the transcriptase reaction primed by either ApG or globin mRNA. These effects of reduced secondary structure also most probably reflect an interaction of the exogenous RNAs with transcriptase protein(s). The results obtained from screening a series of native uncapped ribopolymers were consistent with inhibitory activity requiring the absence of most hydrogen bonding in the ribopolymer and also suggested that specific structural feature(s) of the nucleotides in the chain were important.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6934519      PMCID: PMC350174          DOI: 10.1073/pnas.77.10.5874

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Influenza virion RNA-dependent RNA polymerase: stimulation by guanosine and related compounds.

Authors:  D McGeoch; N Kitron
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Differential synthesis of blocked and unblocked 5'-termini in reovirus mRNA: effect of pyrophosphate and pyrophosphatase.

Authors:  Y Furuichi; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

3.  Effect of 5'-terminal structure and base composition on polyribonucleotide binding to ribosomes.

Authors:  G W Both; Y Furuichi; S Muthukrishnan; A J Shatkin
Journal:  J Mol Biol       Date:  1976-07-05       Impact factor: 5.469

4.  Nucleotide sequence of 5' terminus of alfalfa mosaic virus RNA 4 leading into coat protein cistron.

Authors:  E C Koper-Zwarthoff; R E Lockard; B Alzner-deWeerd; U L RajBhandary; J F Bol
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

5.  Transcription by infectious subviral particles of reovirus.

Authors:  A J Shatkin; A J LaFiandra
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

Review 6.  Synthetic polynucleotides.

Authors:  A M Michelson; J Massoulié; W Guschlbauer
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1967

7.  5'-termini of reovirus mRNA: ability of viral cores to form caps post-transcriptionally.

Authors:  Y Furuichi; A J Shatkin
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

8.  3'-terminal labelling of RNA with T4 RNA ligase.

Authors:  T E England; O C Uhlenbeck
Journal:  Nature       Date:  1978-10-12       Impact factor: 49.962

9.  Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts.

Authors:  J J Skehel; A J Hay
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

10.  Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  19 in total

1.  Mutagenic analysis of the 5' arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity.

Authors:  M B Leahy; D C Pritlove; L L Poon; G G Brownlee
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  In vivo analysis of the TSWV cap-snatching mechanism: single base complementarity and primer length requirements.

Authors:  D Duijsings; R Kormelink; R Goldbach
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  In vitro polymerase activity of Thogoto virus: evidence for a unique cap-snatching mechanism in a tick-borne orthomyxovirus.

Authors:  M B Leahy; J T Dessens; P A Nuttall
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 4.  How does influenza virus regulate gene expression at the level of mRNA translation? Let us count the ways.

Authors:  M S Garfinkel; M G Katze
Journal:  Gene Expr       Date:  1993

5.  Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro.

Authors:  J Bárcena; M Ochoa; S de la Luna; J A Melero; A Nieto; J Ortín; A Portela
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  RNA polymerase of influenza virus. IV. Catalytic properties of the capped RNA endonuclease associated with the RNA polymerase.

Authors:  K Kawakami; K Mizumoto; A Ishihama
Journal:  Nucleic Acids Res       Date:  1983-06-11       Impact factor: 16.971

7.  Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription.

Authors:  I Ulmanen; B A Broni; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Solid phase synthesis of 5'-diphosphorylated oligoribonucleotides and their conversion to capped m7Gppp-oligoribonucleotides for use as primers for influenza A virus RNA polymerase in vitro.

Authors:  G G Brownlee; E Fodor; D C Pritlove; K G Gould; J J Dalluge
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

9.  Modification of eukaryotic initiation factor 4F during infection by influenza virus.

Authors:  D Feigenblum; R J Schneider
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  mRNA 5'-cap binding activity in purified influenza virus detected by simple, rapid assay.

Authors:  H Kroath; A J Shatkin
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.